The firm is currently scrutinizing several high-profile agreements, including the acquisition of Apogee Therapeutics (NASDAQ: APGE) by AbbVie for $135.11 per share in cash. Investigators are also reviewing the sale of Identiv, Inc.’s (NASDAQ: INVE) IoT business and Thai subsidiary to Trackonomy Systems, alongside the merger between Colony Bankcorp (NYSE: CBAN) and First Reliance Bancshares (OTCQX: FSRL).
Attorneys at Halper Sadeh contend that these deals may contain restrictive terms that discourage superior competing offers. The firm is evaluating whether shareholders are receiving adequate compensation and sufficient transparency regarding the long-term impact of these transitions. Affected investors are being encouraged to review their rights, with the firm operating on a contingent fee basis to pursue potential increased consideration or additional corporate disclosures.
Comments (0)
No comments yet. Be the first!